Ashish Gulati
Chief Tech/Sci/R&D Officer at VALERIO THERAPEUTICS
Network origin in Ashish Gulati first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 11 | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.
9
| Subsidiary | Miscellaneous Commercial Services | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ashish Gulati via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | President | |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Executive Officer | |
CSL LIMITED | Biotechnology | Director/Board Member | |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Chief Operating Officer | |
Orthobond Corp.
Orthobond Corp. Chemicals: Major DiversifiedProcess Industries Orthobond Corp. develops chemicals to help facilitate better material surface bonding. It offers a technology based on self-assembled monolayers of phosphonate (SAMP) and osteoconductive self-assembled monolayer of phosphonate surface modification that elicits a biological response on inorganic implants without the use of a biologic. The company was founded by Gregory E. Lutz and Jeffery Schwartz in 2004 and is headquartered in North Brunswick, NJ. | Chemicals: Major Diversified | Director/Board Member | |
CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member | |
Svenskt Näringsliv
Svenskt Näringsliv Miscellaneous Commercial ServicesCommercial Services Svenskt Näringsliv provides consulting services. It focuses on protection, support, and promotion of the interests of businesses. The firm provides its members with knowledge in a number of areas including labor market and law, taxes, corporate law and intellectual property, economics and macro analysis, constitutional and legal protection, security and risk management, and trade policy. The company was founded on March 29, 2001 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Investment Banks/Brokers | Corporate Officer/Principal | |
The Invus Group LLC
The Invus Group LLC Investment ManagersFinance The Invus Group LLC is an Independent Venture Capital firm founded in 1985 by Raymond Debbane. The Invus Group LLC is headquartered in New York, US with additional office in Paris. | Investment Managers | Private Equity Investor | |
Georgetown University | College/University | Undergraduate Degree | |
American University of Beirut | College/University | Undergraduate Degree | |
TECHNOFLEX | Chemicals: Major Diversified | Director/Board Member | |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Chief Executive Officer | |
Invus Public Equities Advisors LLC
Invus Public Equities Advisors LLC Investment ManagersFinance Invus Public Equities Advisors LLC is an investment advisory firm headquartered in New York City. The firm was founded by Raymond Debbane in 1985 and is a subsidiary of The Invus Group LLC. Invus Public Equities Advisors serves as the general partner of Invus Public Equities, L.P. | Investment Managers | Portfolio Manager-Equities | |
École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin | |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
The Olayan Group
The Olayan Group Investment ManagersFinance The Olayan Group operates as a diversified enterprise that engages in trading, manufacturing, services and investments sectors. It manages commercial and industrial operations in Saudi Arabia through its subsidiary Olayan Financing Company. The firm’s investment team focuses on public and private equities, real estate, fixed income securities, and other specialized assets. It operates through its offices located in Europe, Saudi Arabia and the United States. The company was founded by Suliman S. Olayan in 1947 and is headquartered in Riyadh, Saudi Arabia. | Investment Managers | Corporate Officer/Principal | |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Operating Officer | |
Evolva SA
Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Children of Armenia Fund | Director/Board Member | ||
AlchiMedics SA
AlchiMedics SA Chemicals: Major DiversifiedProcess Industries AlchiMedics SA specializes in coating technologies via electrografting. Its products enables covalent adhesion of nano to micrometric polymer-based layers on surfaces. The firm designs, develops and implements electro-grafting technology for implantable biomedical applications. The company was founded in 2007 and is headquartered in Grenoble, France. | Chemicals: Major Diversified | Director/Board Member | |
EPIZYME, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
EVOLVA HOLDING SA | Food: Specialty/Candy | Director/Board Member | |
AstraZeneca Holding GmbH
AstraZeneca Holding GmbH Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca Holding GmbH functions as an investment holding German company. The company is based in Wedel, Germany. The CEO of the company is Hans Sijbesma. | Financial Conglomerates | Chief Executive Officer | |
SENSORION | Pharmaceuticals: Major | Chairman Director/Board Member | |
Roussel NZ Ltd. | Sales & Marketing | ||
École Nationale Vétérinaire d'Alfort | College/University | Doctorate Degree | |
Isocell SA
Isocell SA Food RetailRetail Trade Isocell SA operates as a holding company with interests in the manufacture of food supplements. It develops proprietary formulation for super-oxyde dismutase. The firm also targets food areas including sodas, sport drinks and dairies with wellness claims. It also engages in the ownership and operations of medical laboratories. The company was founded by Francois Vix on July 9, 2001 and is headquartered in Paris, France. | Food Retail | Director/Board Member | |
Svenskt Naringsliv (Research Firm) | Investment Managers | Chief Executive Officer | |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Director/Board Member | |
PROTAGENIC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
GOSSAMER BIO, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
VIELA BIO, INC. | Biotechnology | Director/Board Member | |
Solving Kids Cancer | Director/Board Member | ||
ElevateBio LLC
ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Life Generation Ltd.
Life Generation Ltd. Miscellaneous Commercial ServicesCommercial Services Life Generation Ltd. provides technical and vocational secondary education services. The private company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Svenskt Näringsliv Service AB
Svenskt Näringsliv Service AB Construction MaterialsNon-Energy Minerals Svenskt Näringsliv Service AB is a private company based in Stockholm, SE. Svenskt Näringsliv Service AB produces concrete. The Swedish company was founded in 1972 and the CEO is Jan-Olof Jacke. | Construction Materials | Chief Executive Officer | |
Astrazeneca Sweden Investments Ltd.
Astrazeneca Sweden Investments Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, Astrazeneca Sweden Investments Ltd. is a science-led biopharmaceutical business. The company is based in Cambridge, UK. Astrazeneca's innovative medicines are used by millions of patients worldwide. | Financial Conglomerates | Director/Board Member | |
Centre Detudes Litteraires Et Scientifiques Appliquees | College/University | Graduate Degree |
Statistics
International
United States | 24 |
France | 10 |
United Kingdom | 6 |
Sweden | 4 |
Japan | 3 |
Sectoral
Health Technology | 20 |
Finance | 10 |
Commercial Services | 9 |
Consumer Services | 6 |
Process Industries | 4 |
Operational
Director/Board Member | 87 |
Chairman | 41 |
Corporate Officer/Principal | 24 |
Chief Executive Officer | 16 |
Independent Dir/Board Member | 14 |
Most connected contacts
Insiders | |
---|---|
Per Olof Nordberg | 73 |
Pascal Soriot | 17 |
Khalil Barrage | 15 |
Jean Nicolas Trebouta | 12 |
Philippe Maitre | 11 |
Jacques Mallet | 8 |
Shefali Agarwal | 8 |
Bryan Giraudo | 7 |
Jan-Olof Jacke | 5 |
Herbert Helander | 5 |
Valérie Leroy | 4 |
Julien Miara | 4 |
Audrey Legentil-Duméry | 2 |
Mikael Hansson | 2 |
Robert L Coleman | 2 |
- Stock Market
- Insiders
- Ashish Gulati
- Company connections